N+1 Singer appointed as Nominated Adviser and Sole Broker to Circassia Group plc

N+1 Singer is delighted to announce its appointment as Nominated Adviser and Sole Broker to Circassia Group plc with immediate effect. 

About Circassia Group plc

Circassia is a medical device company focused on respiratory diagnostics and monitoring. Their market-leading NIOX® products are used in clinical settings by physicians around the world to help improve asthma diagnosis and management and by leading research organisations conducting clinical studies on behalf of pharmaceutical companies.

Customers are able to buy products and receive customer service via dedicated teams in the United States, UK, Sweden, Germany and China, on-line in some regions and through a network of global partners.

Ticker: CIR
Market Cap: £115.29 million*
Website: Click here

*As at 12/01/2021

For more information on this news, please email us or call us on +44 (0)20 7496 3000.